Rectal cancer surgery trial: Skipping certain lymph node removal
Part of Cancer, Digestive system clinical trials.
This trial is testing whether a more limited surgery for mid and low rectal cancer can be safe, by avoiding removal of lymph nodes near the main artery. It may be a good fit if your tumor is in the lower rectum, hasn't spread far, and you are in generally good health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a type of colon or rectal cancer called adenocarcinoma (not a rare subtype like mucinous or signet ring cell).
- The lower edge of your tumor is within about 7 cm from your anus (as seen on a colonoscopy or scan).
- Your tumor has not grown deeply (stage T3 or less) and has not spread to distant parts of your body.
- You have no more than three small, cancerous lymph nodes in the area, and none at the root of the main artery.
- You are healthy enough for surgery, without serious other medical conditions or prior cancers in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a strategy to avoid surgery by using watchful waiting after initial treatment for early-stage rectal cancer. It may help patients keep their rectum and avoid a permanent colostomy.
This study compares two robotic surgery techniques for mid/low rectal cancer: one that removes certain lymph nodes and one that preserves them. The goal is to see which approach is safer and better for recovery.
This trial studies a specific change to how surgeons connect a vein during rectal cancer surgery to help prevent cancer cells from spreading. It may be an option if you have early-to-mid stage rectal cancer planned for laparoscopic surgery with curative intent.
This trial looks at whether removing the rectal tumor locally (through the anus) can work as well as a more extensive operation after scans show no remaining cancer. It may help some people avoid bigger surgery if the cancer truly appears gone after treatment.
This trial tests whether people with early- to intermediate-stage low rectal cancer can avoid surgery if their tumor responds well to a full course of chemotherapy and radiation. It starts with brief chemotherapy, then adjusts treatment based on how much the tumor shrinks.
This trial studies removing an early rectal cancer tumor locally (through the rectum/anal area) with no additional therapy afterward. The goal is to preserve organs and maintain quality of life while still trying to cure the cancer.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.